The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma

Annals of Oncology

Volumn 12, Issue 9, 2001, Pages 1239-1245

  Soini, Y ^a   Jarvinen K ^a   Kaarteenaho Wiik, R ^a   Kinnula, V ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chemotherapy; MDR; Mesothelioma; Pleura

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SARCOMA;

ADULT; AGED; DRUG RESISTANCE, MULTIPLE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034778022     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012292230480     Document Type: Article

References (55)

1. Multidrug resistance and its reversal
2. Glutathione-related mechanisms in cellular resistance to anticancer drugs (Review)
3. Multidrug resistance: Molecular mechanisms and clinical relevance
4. Multiple-drug resistance in human cancer
5. MDR1 gene expression in lung cancer
6. Expression of the MRP and MDR1 multidrug resistance gene in small-cell lung cancer
7. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response
8. Export pumps for glutathione S-conjugates
9. A family of drug transporters: The multidrug resistance-associated proteins
10. A 190-kilo-dalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene
11. Transport of glutathione conjugates into secretory vesicles in mediated by the multidrug-resistance protein 1
12. r 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione
13. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multi-specific organic anion transporter (cMOAT), genes correlates with cancer to platinum drugs
14. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas
15. Evidence that the multidrug protein (MRP) functions as a Co-transporter of glutathione and natural product toxins
16. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione
17. γ-Glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer
18. The ATP-dependent glutathione S-conjugate export pump
19. Frequent coexpression of MRP/GS-X pump and γ-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumos cells and normal mouse tissues
20. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress
21. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides
22. MRP is frequently expressed in human lung-cancer cell line, non-small-cell cancer and in normal lungs
23. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas
24. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung
25. Multidrug resistance-associated protein (MRP) gene expressed human lung cancer
26. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer
27. Preferential expression of the multidrug-resistance associated protein (MRP) in adenocarcinoma of the lung
28. Expression of the multidrug resistance-associated protein MRP gene in human lung tumours and normal tissue as determining in situ hydridisation
29. Co-ordinated overexpression of the MRP and γ-glutamylcysteinesynthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines
30. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha
31. Tumors of the serosal membranes
32. Expression of P-glycoprotein in hepatocellular carcinoma: A potential marker of prognosis
33. Measuring repeatability and validity of histological diagnosis - A brief review with some practical examples
34. Clinical relevation of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma
35. Constitutive expression of multidrug resistance in human colorectal tumours and cell lines
36. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles
37. Intracellular expression of P-glycoprotein in a human colon tumor cell line
38. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients
39. Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein
40. Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer
41. Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer
42. Expression of multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer
43. Multidrug resistance-associated protein and mutant p53 protein expression in non-small-cell lung cancer
44. Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer
45. Expression of multidrug resistance-associated protein in endometrial carcinomas: Correlation with clinicopathology and prognosis
46. Expression of multidrug resistance-associated protein (MRP) in head and neck squamous cell carcinoma
47. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas
48. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma
49. Expression of multidrug resistance-associated protein (MRP) in thyroid cancers
50. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small-cell lung cancer cells
51. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma
52. Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma
53. Glutathione-associated enzymes in anticancer drug resistance
54. Anti-oxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells
55. Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity